Literature DB >> 15288732

Diuretics in the LIFE study.

Johji Kato, Tanenao Eto.   

Abstract

Mesh：

Substances：

Year:  2004        PMID： 15288732     DOI： 10.1016/S0140-6736(04)16755-X

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  3 in total

Review 1.  Losartan/Hydrochlorothiazide: a review of its use in the treatment of hypertension and for stroke risk reduction in patients with hypertension and left ventricular hypertrophy.

Authors:  Gillian M Keating
Journal:  Drugs       Date:  2009-06-18       Impact factor: 9.546

2.  Efficacy and Safety of Combination Therapy Consisting of Angiotensin II Type 1 Receptor Blocker, Calcium Channel Blocker and Hydrochlorothiazide in Patients With Hypertension.

Authors:  Yuhei Shiga; Shin-Ichiro Miura; Kota Motozato; Yuka Yoshimine; Kenji Norimatsu; Tadaaki Arimura; Rie Koyoshi; Joji Morii; Takashi Kuwano; Ken Inoue; Tetsuro Shirotani; Kazuaki Fujisawa; Eiyu Matsunaga; Keijiro Saku
Journal:  J Clin Med Res       Date:  2016-12-31

Review 3.  Fixed combination of losartan and hydrochlorothiazide and reduction of risk of stroke.

Authors:  Sverre E Kjeldsen; Paulette A Lyle; Jorge R Kizer; Suzanne Oparil; Aud Høieggen; Ingrid Os
Journal:  Vasc Health Risk Manag       Date:  2007
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.